FEDERAL COURT OF AUSTRALIA
Freedom Pharmaceutical Pty Ltd v Minister for Health [2022] FCAFC 123
Appeal from: Freedom Pharmaceutical Pty Ltd v Minister for Health [2021] FCA 213 File number: NSD 413 of 2021 Judgment of: MARKOVIC, THOMAS AND STEWART JJ Date of judgment: 20 July 2022 Catchwords: ADMINISTRATIVE LAW – appeal from a single judge of the Federal Court of Australia – where primary judge dismissed an application for judicial review of a decision of the Minister made pursuant to s 90A of the National Health Act 1953 (Cth) granting approval to a premises to supply pharmaceutical benefits – where Minister notified the appellant of the request for exercise of discretion and invited comments – whether primary judge erred in holding that notification without further details of the application was sufficient – where Minister concluded that a “community” would be left without “reasonable access” to pharmaceutical benefits if the approval were not granted – where premises in respect of which approval was granted is located approximately 60m from appellant’s pharmacy – whether primary judge erred in construing the scope of the Minister’s discretion – appeal dismissed Legislation: Administrative Decisions (Judicial Review) Act 1977 (Cth) s 5
Health Legislation Amendment (Pharmacy Location Arrangements) Act 2006 (Cth)
National Health Act 1953 (Cth) ss 90, 90A, 90B, 90D, 90K
National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (Cth)
Cases cited: Freedom Pharmaceutical Pty Ltd v Minister for Health [2021] FCA 213
Kong v Minister for Health [2014] FCAFC 149; 227 FCR 215
Minister for Immigration and Multicultural Affairs v Eshetu [1999] HCA 21; 197 CLR 611
Pharmacy Restructuring Authority v Chatfield [1993] FCA 495; 43 FCR 418
Division: General Division Registry: New South Wales National Practice Area: Administrative and Constitutional Law and Human Rights Number of paragraphs: 54 Date of hearing: 28 February 2022 Counsel for the Appellant: C Gunson SC and J Sawyer Solicitor for the Appellant: Robert James Lawyers Counsel for the Respondents: S Free SC and A Lyons Solicitor for the Respondents: Australian Government Solicitor ORDERS
NSD 413 of 2021 BETWEEN: FREEDOM PHARMACEUTICAL PTY LTD
Appellant
AND: MINISTER FOR HEALTH
First Respondent
MAGGIE ROUCHDI
Second Respondent
ORDER MADE BY:
MARKOVIC, THOMAS AND STEWART JJ
DATE OF ORDER:
20 JULY 2022
THE COURT ORDERS THAT:
1.The appeal be dismissed with costs.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
REASONS FOR JUDGMENT
THE COURT:
Introduction
The appellant, Freedom Pharmaceutical Pty Ltd, is the operator of a pharmacy known as TerryWhite Chemmart Blacktown located in the St Martins Village shopping centre in Blacktown, New South Wales. Those premises are approved premises for the supply of pharmaceutical benefits by the appellant under s 90 of the National Health Act 1953 (Cth).
The second respondent, Maggie Rouchdi, is the operator…
Keep reading for free
Create a free CaseChat account to read Freedom Pharmaceutical Pty Ltd v Minister for Health and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] FCAFC 123
- Decision Date
CaseChat Overview and Summary
The primary legal issue that the court had to decide was whether the Minister had erred in his decision to grant approval for the supply of pharmaceutical benefits from the premises in question. The court had to determine whether the Minister had considered the statutory criteria when making his decision and whether the Minister had provided sufficient reasons for his decision. The court also had to consider whether the Minister had correctly interpreted the scope of his discretion under Section 90A of the Act.
In dismissing the appeal, the court held that the Minister had not erred in his decision to grant approval for the supply of pharmaceutical benefits from the premises. The court found that the Minister had properly considered the statutory criteria when making his decision and had provided sufficient reasons for his decision. The court also held that the Minister had correctly interpreted the scope of his discretion under Section 90A of the Act. The court found that the Minister was satisfied that a community would be left without reasonable access to pharmaceutical benefits if the approval were not granted and that it was in the public interest to approve the pharmacist. The court held that the Minister's decision was not Wednesbury unreasonable and was therefore valid.
The court dismissed the appeal and ordered that the appellant pay the respondent's costs. The court held that the appeal was without merit and that the Minister's decision was correctly made. The court found that the Minister had properly considered the statutory criteria and had provided sufficient reasons for his decision. The court also held that the Minister's interpretation of his discretion under Section 90A of the Act was correct. The decision of the court is a reminder of the importance of proper consideration of statutory criteria and the need for sufficient reasons to be provided for administrative decisions.
Orders
Orders of the court
1. The appeal be dismissed with costs.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi